Loading organizations...
Based in Luton, England, Combat Medical is a medical device manufacturer that develops hyperthermic drug delivery systems for advanced oncology treatments. The organization manufactures clinical equipment that integrates directly into existing healthcare practices, utilizing its background in medical device management. Its primary technology supports hyperthermic intraperitoneal chemotherapy (HIPEC) procedures utilized by various regional healthcare systems and specialized oncology clinics. While specific financial metrics such as total funding raised, company valuation, and current employee headcount remain undisclosed, the enterprise is actively seeking additional venture capital investment to scale its commercial operations. Recent corporate filings registered with the United Kingdom Companies House show administrative updates, including a confirmation statement processed on December 3, 2023. Although the exact founding year is not publicly available, Combat Medical was established by co-founder and current Chief Executive Officer Edward Bruce-White.
Combat Medical has raised $348.0M across 1 funding round.
Combat Medical has raised $348.0M in total across 1 funding round.
Combat Medical has raised $348.0M across 1 funding round. Most recently, it raised $348.0M Series A in March 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 12, 2026 | $348M Series A | T&J Meyer Family Foundation | NW Angel Fund, Varia Ventures | Announced |
Combat Medical has raised $348.0M in total across 1 funding round.
Combat Medical's investors include T&J Meyer Family Foundation, NW Angel Fund, Varia Ventures.
